Outlook Therapeutics's total assets for Q3 2025 were $22.39M, an increase of 17.39% from the previous quarter. OTLK total liabilities were $59.58M for the fiscal quarter, a 15.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.